Paula Tena

Mrs. Paula Tena

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2021 in EMBO Reports
Verified
Journal Article
Open access
PDF file
SCSergi Casellas-Díaz
Sergi Casellas-Díaz
RLRaquel Larramona-Arcas
Raquel Larramona-Arcas
GRGuillem Riqué-Pujol
Guillem Riqué-Pujol
PTPaula Tena
Paula Tena
CMClaudia Müller-Sánchez
Claudia Müller-Sánchez
FSFrancesc Xavier Soriano
Francesc Xavier Soriano
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

4 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPEmma Puighermanal
Emma Puighermanal
MLMarta Luna-Sánchez
Marta Luna-Sánchez
AGAlejandro Gella
Alejandro Gella
GWGunter van der Walt
Gunter van der Walt
AUAndrea Urpi
Andrea Urpi
Albert QuintanaAlbert Quintana
Albert Quintana
Mutations in mitochondrial energy-producing genes lead to a heterogeneous group of untreatable disorders known as primary mitochondrial diseases (MD). Leigh syndrome (LS) is the most common pediatric MD and is characterized by progressive neuromuscular affectation and premature death. Here, we show that daily cannabidiol (CBD) administration significantly extends lifespan and ameliorates pathology in two LS mouse models, and improves cellular function in fibroblasts from LS patients. CBD delays motor decline and neurodegenerative signs, improves social deficits and breathing abnormalities, decreases thermally induced seizures, and improves neuropathology in affected brain regions. Mechanistically, we identify peroxisome proliferator-activated receptor gamma (PPARγ) as a key nuclear receptor mediating CBD’s beneficial effects, while also providing proof of dysregulated PPARγ expression and activity as a common feature in both mouse neurons and fibroblasts from LS patients. Taken together, our results provide the first evidence for CBD as a potential treatment for LS.

Verified
Journal Article
Open access
PDF file
PTPaula Tena
Paula Tena
GRGuillem Riqué-Pujol
Guillem Riqué-Pujol
CMClaudia Müller-Sánchez
Claudia Müller-Sánchez
MPManuel Reina del Pozo
Manuel Reina del Pozo
OMOfelia M. Martínez-Estrada
Ofelia M. Martínez-Estrada
FSFrancesc Xavier Soriano
Francesc Xavier Soriano
Synaptic activity is the main energy-consuming process in the central nervous system. We are beginning to understand how energy is supplied and used during synaptic activity by neurons. However, the long-term metabolic adaptations associated with a previous episode of synaptic activity are not well understood. Herein, we show that an episode of synaptic activity increases mitochondrial bioenergetics beyond the duration of the synaptic activity by transcriptionally inducing the expression of iron metabolism genes with the consequent enhancement of cellular and mitochondrial iron uptake. Iron is a necessary component of the electron transport chain complexes, and its chelation or knockdown of mitochondrial iron transporter Mfrn1 blocks the activity-mediated bioenergetics boost. We found that Mfrn1 expression is regulated by the well-known regulator of synaptic plasticity CREB, suggesting the coordinated expression of synaptic plasticity programs with those required to meet the associated increase in energetic demands.